- Home
- GCGR vs ANGO Comparison
GCGR vs ANGO Comparison
Compare GCGR & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$15.81
Company Overview
Basic Information| Metric | GCGR | ANGO |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.3M | 420.2M |
| IPO Year | 2026 | 2004 |
Fundamental Metrics
Financial Performance| Metric | GCGR | ANGO |
|---|---|---|
| Price | $10.10 | $15.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 25.8K | ★ 511.2K |
| Earning Date | N/A | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $10.05 | $8.65 |
| 52 Week High | $10.20 | $16.11 |
Technical Indicators
Market Signals| Indicator | GCGR | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 71.52 |
| Support Level | $10.09 | $10.56 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.01 | 0.50 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 11.11 | 83.04 |
Price Performance
Historical Comparison GCGR
ANGO
About GCGR General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares
General Catalyst Global Resilience Merger Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.